Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Markers of serotonin synapses in entire temporal lobe and frontal and temporal neocortex were examined for changes in Alzheimer's disease by use of both neurosurgical and autopsy samples. Uptake of [3H]serotonin, binding of [3H]imipramine, and content of indolamines were all significantly reduc...
Main Authors: | Bowen, D, Allen, S, Benton, J, Goodhardt, M, Haan, E, Palmer, A, Sims, N, Smith, C, Spillane, J, Esiri, M, Neary, D, Snowdon, J, Wilcock, G, Davison, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1983
|
Registos relacionados
-
Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
Por: Pearce, B, et al.
Publicado em: (1984) -
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
Por: Bowen, D, et al.
Publicado em: (2008) -
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Por: Francis, P, et al.
Publicado em: (1985) -
Complementary roles of serotonergic and cholinergic systems in decisions about when to act
Por: Khalighinejad, N, et al.
Publicado em: (2022) -
Caveolin-3 differentially orchestrates cholinergic and serotonergic constriction of murine airways
Por: M. Keshavarz, et al.
Publicado em: (2018-05-01)